I thought reposting this to be next to the ACEII post might be helpful.
ARBs won’t help
There seems to be alot of confusion/confounding here of ACE and ACE2. It is easy to confuse for sure, science does a crappy job naming things (they all sound so alike but they are different!) which creates these misunderstandings. Maybe this can help.
ACE is a gene called Angiotensin I Converting Enzyme. This gene encodes an enzyme involved in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This enzyme plays a key role in the renin-angiotensin system. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme or cardiovascular pathophysiologies. This mutation is commonly referred to as the ACE insertion/deletion or, more simply ACE I/D. The relative frequency of this mutation in various ethnic populations worldwide has been of interest to scientists (As are the population frequencies of many other mutations in hundreds of genes) as they have bearing on diseases, medications, etc. ACE is NOT related to 2019 novel CoV or SARS at all.
ACE inhibitors produce vasodilation by inhibiting the formation of angiotensin II. (Which is NOT ACE2) This molecule is a potent vasoconstrictor formed by the proteolytic action of renin (released by the kidneys) acting on circulating angiotensinogen to form angiotensin I.
ACE inhibitors end with -pril: benazepril (Lotensin, Lotensin Hct); captopril (Capoten); enalapril (Vasotec); fosinopril (Monopril); lisinopril (Prinivil, Zestril). These medications have nothing to do with Coronaviruses.
Much has been made about the non-peer reviewed study that ACE2 is the putative (considered to be based on available evidence)receptor for the spike protein of novel CoV (and likely this seems true) but even more has been said here by commenters that Asian males are more susceptible because they hav higher expression of ACE2 in lung cells.
https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1
I want to say that study was done on EIGHT samples from a tissue bank of lung tissue from healthy donors. ONE of those samples came from a Asian male and in this tissue sample ACE2 expression was found to be much higher than in other samples, and ACE2 was also being expressed in more cell types. The authors SPECULATE that this observation may underlie the virulence for novel CoV in Asians.
First: this sample size is ridiculously small, it is NOT established fact. It is a very interesting observation that needs to be replicated by another research group in a much larger cohort. I am not a statistician, but there are guidelines for sample size needed in order to obtain results that can be statistically significant. That sample size of EIGHT was insufficiently powered. You can read more here: https://www.statisticsdonewrong.com/power.html
So, if someone looked at tissue samples from 1000 people, 250 each: Africans, Caucasians, Asians and Latinos of roughly half male/female you might get a better idea of the actual ACE2 expression pattern as it varies by ethnicity. BTW: I am not a statistician, so 1000 might not be sufficiently powered (or may be overpowered) …but you get the idea.
Also, when you read the comments associated with this study, several people (way smarter than me, who work in this area of science) point out some problems with the methodologies used in the research. I cannot comment on this, as I am not a subject matter expert in this area, but I am very clear this happens alot……it is only people who work in these highly specialized niche areas of research who can understand these subtleties.
But what about ACE2? https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACE2&keywords=ACE2
First, it is not ACE, it is also not angiotensin II.
ACE2 (Angiotensin I Converting Enzyme 2) is a gene that encodes an enzyme which converts angiotensin I to angiotensin 1-9, a peptide of unknown function, and angiotensin II to angiotensin 1-7, a vasodilator (PubMed:10969042, PubMed:10924499, PubMed:11815627). Also able to hydrolyze apelin-13 and dynorphin-13 with high efficiency (PubMed:11815627). By cleavage of angiotensin II, may be an important regulator of heart function (PubMed:10969042, PubMed:10924499). By cleavage of angiotensin II, may also have a protective role in acute lung injury (By similarity). Plays an important role in amino acid transport by acting as binding partner of amino acid transporter SL6A19 in intestine, regulating trafficking, expression on the cell surface, and its catalytic activity (PubMed:18424768, PubMed:19185582). ACE2_HUMAN,Q9BYF1
ACE2 also acts as a receptor for SARS coronavirus/SARS-CoV. ACE2_HUMAN,Q9BYF1
What apparently makes novel CoV so serious for some is this surface expression of ACE2 protein on lung alveolar epithelial cells. ACE2 is poorly expressed in the upper respiratory tract: nose, sinus tissue, throat, but gets expressed in the lung. Hence, many people develop a fever and shortness of breathe, pneumonia and never really get a “cold” prior: sneezing, sore throat.
In short high/upregulated ACE is bad: think high blood pressure. Hence ACE inhibitors to block it.
ACE2 is good. An upregulated ACE2 (not angiotensin II) is actually regarded beneficial in cardiovascular and kidney disease. Perhaps having alot of ACE2 expressed in lung tissue ends up being bad for CoV infection though…and the result of that infection is the down regulation/inhibition of ACE2’s positive effects.
Stephen Buhner mentions in his book, page 55: “SARS viruses attach to ACE-2 on the surface of lung, lymph, and spleen epithelial cells. (Licorice, Chinese skullcap, luteolin, horse chestnut, Polygonum spp., Rheum officinale, and plants high in pro- cyanidins and lectins such as elder and cinnamon block attachment to varying degrees.)”. Unfortunately the research supporting this statement tends to be highly technical in-vitro experiments with purified constituents, not real life/in vivo clinical trials involving 2019 novel coronavirus. But hey, it is something to look at seriously. Herbs are powerful used correctly.
And what about using ARBs? These drugs end in -sartan. Azilsartan (Edarbi); candesartan (Atacand), valsartan (Diovan); losartan (Cozaar); olmesartan (Benicar).
ARB stands for AT1R blockers and they represent a major class of antihypertensive medications.
Angiotensin-II (not ACE2) activates two major types of receptors, angiotensin II type one (AT1R) and type two (AT2R) receptors. While AT1R is widely expressed and mediates most inflammatory Ang-II effects (bad), AT2R, is less expressed and has opposite effects, promoting vasodilation and anti-inflammatory effects [1] . Physiologically, AT2R actions are usually masked by the more abundant AT1R. It has been suggested that ARBs can mediate their action through increasing angiotensin II (Ang II) availability to bind to the beneficial angiotensin type 2 receptor (AT2R), thus leading to unopposed AT2R stimulation.
So long story short, ARBs do not block the gene or the enzyme ACE2. They block the receptor for Angiotensin 2 (AT1R: which is produced by ACE, not ACE2).
I know, it is crazy to sort out. But trust me, ACE inhibitors and ARBs have nothing to do with fighting coronavirus infection. What is needed are antiviral meds or herbs that work on multiple levels:
- Block the receptor on ACE2 so the spike protein of novel CoA cannot attach
- Stop the endocytosis of the virus into the cell
- Stop/slow viral replication with in the cell.
- Activation of host defense systems
- Many other strategies: https://www.ncbi.nlm.nih.gov/pubmed/25108320